| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/AAS.12739 |
| P698 | PubMed publication ID | 27113810 |
| P50 | author | Stein Kaasa | Q12002891 |
| Frank Skorpen | Q42754223 | ||
| Pål Klepstad | Q38136464 | ||
| Ola Dale | Q38136651 | ||
| P2093 | author name string | A H Skogholt | |
| M Bjørngaard | |||
| S von Hofacker | |||
| P2860 | cites work | Intravenous opioid dosing and outcomes in emergency patients: a prospective cohort analysis | Q42913619 |
| Ethnicity influences morphine pharmacokinetics and pharmacodynamics | Q43775267 | ||
| A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain | Q44341121 | ||
| The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease | Q44347117 | ||
| mu Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality | Q44348420 | ||
| Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients | Q44349850 | ||
| The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients | Q46520044 | ||
| Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study | Q47919321 | ||
| G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization | Q28276743 | ||
| Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia | Q28585437 | ||
| The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology | Q29615701 | ||
| A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling | Q31532158 | ||
| COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor | Q33964426 | ||
| Opioid rotation for toxicity reduction in terminal cancer patients | Q34305300 | ||
| Opioids and their receptors: Are we there yet? | Q34437456 | ||
| The N-terminally truncated µ3 and µ3-like opioid receptors are transcribed from a novel promoter upstream of exon 2 in the human OPRM1 gene | Q34948489 | ||
| Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives | Q35941387 | ||
| Pain sensitivity and opioid analgesia: a pharmacogenomic twin study | Q36040669 | ||
| Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids | Q36751995 | ||
| Functional characterization of human variants of the mu-opioid receptor gene | Q37249905 | ||
| Establishing "best practices" for opioid rotation: conclusions of an expert panel | Q37593253 | ||
| µ-opioid receptor gene variant OPRM1 118 A>G: a summary of its molecular and clinical consequences for pain | Q38162871 | ||
| A Systematic Review of Prospective Studies Reporting Adverse Events of Commonly Used Opioids for Cancer-Related Pain: A Call for the Use of Standardized Outcome Measures. | Q38519237 | ||
| Assessing the response to opioids in cancer patients: a methodological proposal and the results | Q39197627 | ||
| Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene | Q41157124 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | opioid | Q427523 |
| P304 | page(s) | 1084-1091 | |
| P577 | publication date | 2016-04-26 | |
| P1433 | published in | Acta Anaesthesiologica Scandinavica | Q59829 |
| P1476 | title | The rare Arg181Cys mutation in the μ opioid receptor can abolish opioid responses | |
| P478 | volume | 60 |
| Q56674183 | Structure of the µ-opioid receptor–Gi protein complex | cites work | P2860 |
Search more.